Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis

Figure 6 Effects of fetal kidney stem cells on apoptosis and proliferation of tubular cells in cisplatin injured kidney. A: Quantification of dUTP nick-end labeling (TUNEL)-positive cells in kidney sections of saline and fetal kidney stem cells (fKSC) treated groups at day 3 and 7 after fKSC therapy; B: Quantification of proliferating cell nuclear antigen (PCNA)-positive cells in kidney sections of saline and fKSC treated groups at day 3 and 7 after fKSC therapy. Values expressed mean ± SE. ^aP < 0.05 for fKSC vs saline treated group. HPF: High-power field.